Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines

Differentiation. 2012 Nov;84(4):330-43. doi: 10.1016/j.diff.2012.07.006. Epub 2012 Aug 18.

Abstract

The heterogeneous nature of stem cells is an important issue in both research and therapeutic use in terms of directing cell lineage differentiation pathways, as well as self-renewal properties. Using flow cytometry we have identified two distinct subpopulations by size, large and small, within cultures of human embryonic stem (hES) cell lines. These two cell populations respond differentially to retinoic acid (RA) differentiation and several endocrine disruptor compounds (EDC). The large cell population responds to retinoic acid differentiation with greater than a 50% reduction in cell number and loss of Oct-4 expression, whereas the number of the small cell population does not change and Oct-4 protein expression is maintained. In addition, four estrogenic compounds altered SSEA-3 expression differentially between the two cell subpopulations changing their ratios relative to each other. Both populations express stem cell markers Oct-4, Nanog, Tra-1-60, Tra-1-80 and SSEA-4, but express low levels of differentiation markers common to the three germ layers. Cloning studies indicate that both populations can revive the parental population. Furthermore, whole genome microarray identified approximately 400 genes with significantly different expression between the two populations (p<0.01). We propose the differential response to RA in these populations is due to differential gene expression of Notch signaling members, CoupTF1 and CoupTF2, chromatin remodeling and histone modifying genes that render the small population resistant to RA differentiation. The findings that hES cells exist as heterogeneous populations with distinct responses to differentiation signals and environmental stimuli will be relevant for their use for drug discovery and disease therapy.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Antigens, Differentiation / metabolism
  • Antigens, Surface / biosynthesis
  • Antigens, Tumor-Associated, Carbohydrate / biosynthesis
  • Apigenin / pharmacology
  • COUP Transcription Factor II / biosynthesis
  • Cell Cycle / drug effects
  • Cell Differentiation / drug effects*
  • Cell Line
  • Chlordecone / pharmacology
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / drug effects*
  • Embryonic Stem Cells / metabolism
  • Endocrine Disruptors / pharmacology*
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental
  • Homeodomain Proteins / biosynthesis
  • Humans
  • Kaempferols / pharmacology
  • Nanog Homeobox Protein
  • Octamer Transcription Factor-3 / biosynthesis
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / metabolism
  • Proteoglycans / biosynthesis
  • Signal Transduction / drug effects
  • Stage-Specific Embryonic Antigens / biosynthesis
  • Tamoxifen / pharmacology
  • Tretinoin / pharmacology*

Substances

  • Antigens, Differentiation
  • Antigens, Surface
  • Antigens, Tumor-Associated, Carbohydrate
  • COUP Transcription Factor II
  • Endocrine Disruptors
  • Homeodomain Proteins
  • Kaempferols
  • NANOG protein, human
  • NR2F2 protein, human
  • Nanog Homeobox Protein
  • Octamer Transcription Factor-3
  • Proteoglycans
  • Stage-Specific Embryonic Antigens
  • TRA-1-60 antigen, human
  • stage-specific embryonic antigen-3
  • stage-specific embryonic antigen-4
  • Tamoxifen
  • Tretinoin
  • kaempferol
  • Apigenin
  • Chlordecone